IRIS
CANONICA, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.331
AS - Asia 15.393
EU - Europa 7.692
SA - Sud America 6.217
AF - Africa 1.019
Continente sconosciuto - Info sul continente non disponibili 962
OC - Oceania 39
AN - Antartide 1
Totale 58.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.421
SG - Singapore 8.699
BR - Brasile 5.000
IT - Italia 3.212
VN - Vietnam 2.517
CN - Cina 2.072
FI - Finlandia 975
IE - Irlanda 847
NG - Nigeria 601
DE - Germania 563
AR - Argentina 503
FR - Francia 481
CA - Canada 462
GB - Regno Unito 434
NL - Olanda 317
IN - India 288
HK - Hong Kong 269
RU - Federazione Russa 258
TR - Turchia 245
BD - Bangladesh 238
EC - Ecuador 229
ID - Indonesia 220
MX - Messico 183
CO - Colombia 140
IQ - Iraq 129
ZA - Sudafrica 128
IL - Israele 127
SE - Svezia 127
UA - Ucraina 99
PY - Paraguay 93
PK - Pakistan 79
CL - Cile 76
VE - Venezuela 75
PL - Polonia 67
ES - Italia 64
SA - Arabia Saudita 63
UZ - Uzbekistan 56
EG - Egitto 47
MA - Marocco 46
KE - Kenya 45
UY - Uruguay 42
JM - Giamaica 40
JP - Giappone 40
TN - Tunisia 40
PE - Perù 35
PH - Filippine 32
DZ - Algeria 31
KR - Corea 31
AU - Australia 30
BE - Belgio 29
TT - Trinidad e Tobago 28
HN - Honduras 27
NP - Nepal 27
CR - Costa Rica 26
AZ - Azerbaigian 24
GT - Guatemala 24
JO - Giordania 24
DO - Repubblica Dominicana 23
RO - Romania 23
AE - Emirati Arabi Uniti 22
SC - Seychelles 22
BO - Bolivia 21
CZ - Repubblica Ceca 21
IR - Iran 20
KZ - Kazakistan 20
AT - Austria 19
ET - Etiopia 18
MY - Malesia 18
PR - Porto Rico 18
SV - El Salvador 18
AL - Albania 17
BG - Bulgaria 15
NI - Nicaragua 15
OM - Oman 15
PA - Panama 15
KG - Kirghizistan 14
GR - Grecia 13
LT - Lituania 13
PT - Portogallo 12
SN - Senegal 11
SY - Repubblica araba siriana 11
AM - Armenia 10
LB - Libano 10
GE - Georgia 9
KW - Kuwait 9
MN - Mongolia 9
PS - Palestinian Territory 9
TH - Thailandia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BA - Bosnia-Erzegovina 8
CH - Svizzera 8
RS - Serbia 8
BB - Barbados 7
BH - Bahrain 7
EE - Estonia 7
MD - Moldavia 7
NO - Norvegia 7
AO - Angola 6
DK - Danimarca 6
HR - Croazia 6
Totale 57.589
Salva come PNG Salva come JPEG
Città #
Wilmington 4.540
Singapore 3.414
San Mateo 1.697
The Dalles 1.555
Milan 1.368
Ashburn 1.213
Dallas 1.185
Ann Arbor 1.033
Shanghai 1.010
Helsinki 972
Ho Chi Minh City 925
Leawood 866
Dublin 840
Council Bluffs 826
Princeton 812
Lawrence 775
San Jose 726
Rome 644
Benin City 594
Fairfield 585
Hanoi 524
Woodbridge 519
Chandler 489
São Paulo 420
Paris 403
Santa Clara 341
Beijing 333
New York 307
Los Angeles 304
Amsterdam 273
Hong Kong 251
London 197
Toronto 190
Kocaeli 168
Orem 155
Rio de Janeiro 145
Falkenstein 141
Phoenix 114
Boardman 112
Figino 106
Haiphong 105
Norwalk 104
Buffalo 103
Bradenton 98
North Bergen 98
Chicago 97
Turin 97
Da Nang 94
Brasília 91
Curitiba 88
Guayaquil 88
Philadelphia 86
Belo Horizonte 84
Houston 80
Naples 80
Porto Alegre 75
Montreal 72
Chennai 69
Brooklyn 67
Campinas 66
Biên Hòa 65
Charlotte 64
Atlanta 63
Guarulhos 62
Dhaka 58
Manchester 58
Quito 58
Seattle 55
Salvador 52
Warsaw 52
Tashkent 51
Johannesburg 48
Mansfield 48
Ellicott City 47
Frankfurt am Main 46
Buenos Aires 45
Hải Dương 44
Miami 44
Queens 44
Asunción 43
Bologna 43
Florence 43
Monmouth Junction 43
Moscow 43
Cincinnati 41
Jakarta 41
Mumbai 41
Newark 40
San Diego 40
Denver 39
Ninh Bình 39
Birmingham 38
Montevideo 38
Mexico City 37
Ribeirão Preto 37
Baghdad 36
Las Vegas 36
Nairobi 36
Sorocaba 35
Altamonte Springs 34
Totale 34.641
Salva come PNG Salva come JPEG
Nome #
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco 761
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis 302
Quality of life and polysensitization in young men with intermittent asthma 223
A critical appraisal on AIT in childhood asthma. 174
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study 148
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 143
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 141
Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis--a randomized controlled study 141
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 136
An academic allergy unit during COVID-19 pandemic in Italy. 126
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 125
30 Years Of Sublingual Immunotherapy 125
A Charter to Improve Patient Care in Severe Asthma 122
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 120
Pidotimod: The state of art 119
Work productivity in rhinitis using cell phones: The MASK pilot study 119
The Severe Asthma Network in Italy: Findings and Perspectives 116
A 4-year trial of tiotropium in chronic obstructive pulmonary disease 116
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 115
A new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy 114
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 113
60Co therapy as an "allergic breakthrough" in a case of food allergy 112
A multi-allergen ELISA screening method. Comparison with Pharmacia CAP system and Phazet skin prick test 112
Treatable traits in chronic rhinosinusitis with nasal polyps 112
2019 ARIA Care pathways for allergen immunotherapy 110
A model of allergen-driven human airway contraction:beta2 pathway dysfunction without cytokine involvement 106
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress 106
Comparison of the colony forming capacities of human T lymphocyte subpopulations 105
Assessing biomarkers in a real-world severe asthma study (ARIETTA) 104
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper 103
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life 103
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 102
Meta analysis of SLIT in children 102
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU 102
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 101
Strategies to reduce corticosteroid-related adverse events in asthma 101
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes 101
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe 101
[GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases] 101
Clinical Characteristics Associated with Conjunctival Inflammation in Allergic Rhinoconjunctivitis 100
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) 99
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 98
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 98
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 97
International consensus on allergy immunotherapy 97
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis 97
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 97
Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study 97
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 97
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma 96
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects 96
New drugs in early-stage clinical trials for allergic rhinitis 95
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics 95
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 95
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update 94
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria 94
BEST Study Group. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma 94
[Our experience in the treatment of bronchial asthma and asthmatic bronchitis with salbutamol] 94
Pilot study of mobile phone technology in allergic rhinitis in European countries: The MASK-rhinitis study 94
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice 94
EAACI guidelines on allergen immunotherapy: Executive statement 93
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials 93
Microarray Immunodiagnostics for Aeroallergens 92
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 92
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 92
EAACI/GA2LEN/EDF guideline: management of urticaria 92
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL) 91
[Anti-leukotriene agents: rationale for and prospects of use] 91
A WAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnostics 91
Umeclidinium for the treatment of uncontrolled asthma 91
Cross-Country Comparison of Demographic and Clinical Characteristics of Patients Managed in Severe Asthma Services Across UK, USA, Australia, South Korea, and Italy 91
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 90
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone 90
Role of leukotrienes receptors antagonista in the management of mild-to-moderate asthma 90
Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva allergen challenge 90
[ICAM-1 and allergic inflammation] 90
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters 89
A survey of the burden of allergic rhinitis in Europe 89
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy 88
Local Side Effects of Sublingual and Oral Immunotherapy 88
Allergen immunotherapy as add-on to biologic agents 88
Allergen Immunotherapy (AIT): A prototype of Precision Medicine 88
Sublingual immunotherapy: update 2006 88
Do Asthmatic Patients and Their Physicians Agree on the Presence and Severity of Allergic Rhinitis? 88
A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis 88
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics 88
A critical evaluation of Anti-IL-13 and Anti-IL-4 strategies in severe asthma 88
Escaping the trap of allergic rhinitis. 87
Seasonal and perennial allergic rhinitis: is this classification adherent to real life? 87
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision 87
Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions 87
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report 87
Why a registry of Chronic Urticaria (CUR) is needed 87
Cytokines and airways: recent insights and therapeutic implications 87
Cetirizine treatment of allergic cough in children with pollen allergy 87
General strategy for the management of bronchial asthma in pregnancy 87
The relationship between allergen immunotherapy and omalizumab for treating asthma 86
Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review 86
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy 86
The patient with rhinitis in the pharmacy. A cross-sectional study in real life 86
Totale 11.057
Salva come PNG Salva come JPEG
Categoria #
all - tutte 398.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 398.767
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.115 0 0 0 0 15 17 130 610 304 295 680 64
2022/20234.261 1.617 85 825 139 101 86 19 93 282 774 218 22
2023/20243.395 168 387 769 31 32 141 119 116 50 34 638 910
2024/20255.980 79 34 38 53 56 786 211 381 704 1.955 748 935
2025/202624.138 2.647 1.455 2.593 5.006 661 506 3.665 1.334 1.353 1.101 650 3.167
2026/20278.860 3.298 1.188 2.760 1.366 248 0 0 0 0 0 0 0
Totale 58.654